{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Proventil&page=15", "query": { "intervention": "Proventil", "page": 15 }, "page_size": 10 }, "pagination": { "page": 15, "page_size": 10, "total_count": 387, "total_pages": 39, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Proventil&page=16&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Proventil&page=14&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T11:26:57.737Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00268216", "title": "Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol 50mcg/ Fluticasone Propionate 500mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 6228, "start_date": "2000-09", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 190, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Mobile, Alabama + 152 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00268216" }, { "nct_id": "NCT06154304", "title": "BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bronchial Asthma" ], "interventions": [ { "name": "Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)", "type": "DRUG" }, { "name": "Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1", "type": "DRUG" }, { "name": "Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cipla Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 120, "start_date": "2023-12-06", "completion_date": "2024-11-29", "has_results": false, "last_update_posted_date": "2025-07-16", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 1, "location_summary": "Medford, Oregon", "locations": [ { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06154304" }, { "nct_id": "NCT00667407", "title": "Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Levalbuterol 1.25 mg", "type": "DRUG" }, { "name": "Racemic Albuterol Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 627, "start_date": "2000-11", "completion_date": "2002-08", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 28, "location_summary": "Hoover, Alabama • Montgomery, Alabama • Encinitas, California + 25 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Encinitas", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00667407" }, { "nct_id": "NCT01192178", "title": "Fall Epidemic Viral Pediatric Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FLOVENT™ DISKUS™ 100 mcg BID", "type": "DRUG" }, { "name": "ADVAIR™ DISKUS™ 100/50 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 339, "start_date": "2010-08", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 38, "location_summary": "Tucson, Arizona • Bakersfield, California • Fresno, California + 33 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01192178" }, { "nct_id": "NCT01056159", "title": "A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol dry powder inhaler", "type": "DRUG" }, { "name": "Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 47, "start_date": "2010-01", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2022-02-02", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 9, "location_summary": "Los Angeles, California • Denver, Colorado • Lakewood, Colorado + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Normal", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01056159" }, { "nct_id": "NCT03207243", "title": "Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GSK3772847", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2017-09-14", "completion_date": "2019-05-15", "has_results": true, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Scottsboro, Alabama • Bakersfield, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207243" }, { "nct_id": "NCT01312961", "title": "Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo (for Dupilumab)", "type": "DRUG" }, { "name": "Fluticasone/Salmeterol combination therapy", "type": "DRUG" }, { "name": "Fluticasone monotherapy", "type": "DRUG" }, { "name": "Albuterol", "type": "DRUG" }, { "name": "Levalbuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 104, "start_date": "2011-03", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2017-06-08", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 50, "location_summary": "Anaheim, California • Long Beach, California • Los Angeles, California + 42 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01312961" }, { "nct_id": "NCT00929110", "title": "1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Glycopyrronium bromide", "type": "DRUG" }, { "name": "Placebo to glycopyrronium bromide", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1066, "start_date": "2009-06", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-08-17", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 75, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 68 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00929110" }, { "nct_id": "NCT00355342", "title": "Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol 50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 mcg BID", "type": "DRUG" }, { "name": "DISKUS inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 186, "start_date": "2004-04-28", "completion_date": "2007-09-06", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 37, "location_summary": "Berkeley, California • Fullerton, California • Rancho Mirage, California + 31 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00355342" }, { "nct_id": "NCT01079130", "title": "Efficacy and Safety of Different Doses of Indacaterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo to Indacaterol", "type": "DRUG" }, { "name": "Placebo to Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2010-02", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-08-19", "last_synced_at": "2026-10-23T11:26:57.737Z", "location_count": 71, "location_summary": "Glendale, Arizona • Scottsdale, Arizona • Encinitas, California + 64 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01079130" } ] }